Abivax S.A.
ABVX.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €0 | €0 | €0 | €0 |
| - Cash | €0 | €0 | €0 | €0 |
| + Debt | €0 | €0 | €0 | €0 |
| Enterprise Value | €0 | €0 | €0 | €0 |
| Revenue | €0 | €0 | €0 | €0 |
| % Growth | 133.5% | 0.8% | 12,286.5% | – |
| Gross Profit | €0 | €0 | €0 | -€0 |
| % Margin | 100% | 97.2% | 98.5% | -321.6% |
| EBITDA | -€0 | -€0 | -€0 | -€0 |
| % Margin | -1,553.8% | -2,882.6% | -1,163.3% | -114,040.5% |
| Net Income | -€0 | -€0 | -€0 | -€0 |
| % Margin | -1,633.1% | -3,197.1% | -1,325.3% | -114,735.1% |
| EPS Diluted | -2.8 | -3.43 | -3.18 | -2.75 |
| % Growth | 18.4% | -7.9% | -15.6% | – |
| Operating Cash Flow | -€0 | -€0 | -€0 | -€0 |
| Capital Expenditures | -€0 | -€0 | -€0 | -€0 |
| Free Cash Flow | -€0 | -€0 | -€0 | -€0 |